Julie Waras Brogren in

Julie Waras Brogren

Login to view DISC.
Member of the Board of Directors (EIC Fund Corp. Board Rep. BOYDSense and TILT Biotherapeutics) at European Innovation Council Fund (BOYDSense and TILT Biotherapeutics)
📍 Copenhagen Metropolitan Area, Denmark

Julie Waras Brogren is a life science executive with over 25 years of experience, recently appointed CEO of Gedea Biotech. Her career spans C-level roles in finance and commerce at Ascelia Pharma and leadership positions at Novo Nordisk, focusing on orphan oncology, womens health, and global product launches. She is described as hard-working, commercially driven, and sharp.

She is passionate about bringing breakthrough innovations to market to help patients with unmet medical needs. Julie has completed the Advanced Board Programme at INSEAD, valuing the network of remarkable leaders, and serves on the board of the European Innovation Council Fund, supporting early-stage innovation and strengthening European entrepreneurship.

Julie is inspired by advancing healthcare innovation from development to market, a mission that has defined her career across big pharma and startups.

Read the full overview →
Experience
23 Years
Current Role
Member of the Board of Directors (EIC Fund Corp. Board Rep. BOYDSense and TILT Biotherapeutics)
Job Level
Leadership
Location
Copenhagen Metropolitan Area, Denmark
Personality Overview

How Julie shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Julie cares about

Women's Health
Her new role as CEO of Gedea Biotech, a company focused on women's health, aligns with her stated expertise in this therapeutic area.
Orphan Oncology
This was a primary focus during her tenure as Deputy CEO at Ascelia Pharma and is a core area of her professional background.
+5 more topics Login to view topics
Career

Work history

3-2025
Member of the Board of Directors (EIC Fund Corp. Board Rep. BOYDSense and TILT Biotherapeutics)
European Innovation Council Fund (BOYDSense and TILT Biotherapeutics)
5-2024
Member of the Board of Directors
Implexion Pharma
4-2024
Member of the Board of Directors
PILA PHARMA
8-2023
Deputy CEO (CFO, CCO, Business Development), Ascelia Pharma (Nasdaq: ACE)
Ascelia Pharma AB
10-2022 - 9-2023
Deputy CEO & Chief Commercial Officer
Ascelia Pharma AB
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1993 - 2001
Master of Science (MSc) and Bachelor of Science (BSc)
Copenhagen Business School
Advanced Board Programme
INSEAD
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Julie. Free, 10 seconds.